Ocimum Biosolutions Exposes Biotracker
Hyderabad, India, January 27, 2009: In an unrivaled move, Ocimum Biosolutions, a leading integrated genomics company, based in Hyderabad, India, is unveiling its Biotracker™ R&D Life Science LIMS technology to its customers and partners. In the latest Biotracker™ 4.1 release, all the LIMS methods are now accessible through advanced Web Services based API, as well as a Java based API. The Biotracker™ application program interface is a robust set of routines, protocols, and tools useful to extend the functionality of LIMS system to support the changing needs in drug research and development Environment. “ What this means is that genomics universities and companies can advance Biotracker™ to support new biotech platforms and core competency advancements”, says Ms. Anu Acharya, Founder & CEO of Ocimum Biosolutions. “At Ocimum, we provide global solutions to enable biological decision making, perform biological services, and supply biological molecules.”
Based on the Bioframe© multi-tier platform, Biotracker™ executes across an independent database layer, a business layer handling business logic rules and validation requirements, and a full featured presentation layer. “In providing all the building blocks in Biotracker™, our unique API makes it easier for our customers and consulting partners to develop advanced research applications”, says Sridhar Reddy, VP LIMS Development. Biotracker™ LIMS serves life science R&D genomic operations in pharmaceutical, biotechnology, academic, and research institutes.
Biotracker 4.1 also includes over 100 core enhancements that significantly improves searching, reporting, auditing, processing, and usability. “The best ideas from our customers have been enhanced and are now available to our install base”, says Sridhar. Features improving 2D barcodes, chain of custody, check in/out, and more capabilities to provide researchers the power to manage complex processes. The Biotracker™ API functionality lays the foundation to allow Ocimum to become partners with significant organizations, such as the Cancer Biomedical Informatics Grid (caBIG). Realizing the importance of partnerships with customers and global partners, Ocimum Biosolutions continues to meet the needs of our international customers by expanding the breath of our offerings.
About Ocimum Biosolutions
Ocimum Biosolutions is a leading integrated genomics company providing comprehensive genomic reference databases, life science lab information management solutions, GLP-compliant microarray services and essential research consumables. Over 2/3rd of the top 25 pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred outsourcing partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers.
We are a preferred outsourcing partner for providing integrated biorepository and genomic services for several global pharmaceutical companies. Our global infrastructure, standardized procedures, capacity, expertise and highly skilled staff support drug development programs from pre-clinical target development and toxicogenomic assessment to clinical biomarker identification and patient stratification. In creating the world’s largest commercial gene expression databases – BioExpress® and ToxExpress®, we have developed expertise and capabilities that are unparalleled in the genomic services industry. Our specialty LIMS solution, Biotracker™ caters to the growing needs of core labs in global companies and research centers involved in Life Science Research. We provide multiple GLP-compliant platforms for gene expression and SNP genotyping data generation. We also provide full biorepository and genomic services support for the Genetic Alliance, which is an umbrella organization representing ~600 genetic advocacy groups. Besides providing the physical infrastructure for storing thousands of biological samples, we provide services to assist sample accrual, IRB approvals, CRO training, sample collection, clinical data capture and management.
For more information, please visit www.ocimumbio.com/lims
| Media Contact Dr. Ashwin Sivakumar Director Marketing – Alliances and Outreach Ocimum Biosolutions +91 40 66627200 E-mail: pr@ocimumbio.com |
Investor Contact |
